HALISTER: AbbVie to Acquire Cancer Drugmaker Stemcentrx for $5.8 Billion

AbbVie to Acquire Cancer Drugmaker Stemcentrx for $5.8 Billion

Alert: HALISTER
Source: BN (Bloomberg News)

Tickers
ABBV US (AbbVie Inc)

People
Michael Severino (AbbVie Inc)
Richard Gonzalez (AbbVie Inc)

To de-activate this alert, click here
To modify this alert, click here

UUID: 7947283